Repligen | RGEN - 销售成本

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 6.32B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	销售成本	更改		日
Agilent	USD 852M		19M	2025-12
Align Technology	USD 303.5M		60.47M	2026-03
Bio Techne	USD 103.13M		1.47M	2026-03
BioMarin Pharmaceutical	USD 199.48M		37.93M	2026-03
Bristol-Myers Squibb	USD 3.86B		1.07B	2026-03
Bruker	USD 443.6M		84.4M	2026-03
Charles River Laboratories	USD 716.51M		5.76M	2026-03
Danaher	USD 2.36B		512M	2026-03
Dentsply International	USD 453M		65M	2026-03
General Electric Aerospace	USD 8.15B		764M	2026-03
Henry Schein	USD 2.3B		145M	2026-03
Illumina	USD 370M		30M	2026-03
IQVIA Holdings	USD 3.08B		161M	2026-03
Mettler Toledo International	USD 410.92M		63.05M	2026-03
Myriad Genetics	USD 63M		1.1M	2025-12
OraSure Technologies	USD 15.43M		113K	2025-12
Pacific Biosciences Of California	USD 28.9M		10M	2025-12
Pfizer	USD 4.59B		1.7B	2026-03
Repligen	USD 85.97M		8.11M	2026-03
Revvity	USD 323.46M		26.93M	2026-03
Standard Biotools	USD 12.41M		2.34M	2025-12
Thermo Fisher Scientific	USD 6.96B		620M	2026-03
Waters	USD 725M		350.06M	2026-03
West Pharmaceutical Services	USD 548.5M		47.4M	2026-03